• Disease models and microphysiological systems
  • Emerging technologies: stem cells incl. hiPSCs, bioprinting, spheroids, organoids, multi-organ models, “-omics” analysis, systems biology approaches, IT and big data
  • Biological barriers: e.g. lung, gut, kidney & skin epithelia, blood-brain & blood-saliva barriers
  • Animal-free human based cell culture – replacement of serum, matrigel, gelatin, collagens, trypsin, S9, etc. – and recombinant antibodies
  • Good cell culture practice
  • Development and implementation of Novel Approach Methodologies (NAMs)
  • In silico models: toxicology & efficacy of drugs, chemicals & cosmetics, new approaches for biomedical research
  • In vitro toxicology: Specific endpoints of toxicity, alternatives to animal testing in food safety and nutrition, Neurotoxicity & Developmental Neurotoxicity (DNT) and Ecotoxicology
  • Efficacy and safety testing of drugs, medical devices, biopharmaceutics, cosmetics, consumer products (e. g. toys) and chemicals (REACH & alternatives)


  • Preregistration, reporting, and experimental design
  • Organ and tissue sharing and approaches to reduce surplus animals
  • Translational aspects (species differences) and reproducibility


  • Best practice approaches and culture of care
  • Avoidance of severe suffering and pain management/assessment
  • Cage enrichment and non-invasive handling

  • AI – Artificial Intelligence to advance the Three Rs and human centered research and testing: research/screening tools, creation and use of virtual animal and human populations for pre- and clinical studies, translation tool from animals to humans
  • NGRA – Next generation risk assessment
  • Animal research ethics: 3R, Harm-Benefit Analysis, ethical review
  • 3Rs in education and academia
  • 3Rs centres and platforms in Europe & international, national and local centres
  • 3Rs and policy: Implementing 3Rs guidelines and concepts, Novel Approach Methodologies (NAMs) and Directives – Ethical and legal issues – Cosmetics testing ban (and REACH)
  • 3Rs research funding
  • COST Action IMPROVE: 3Rs concepts to improve the quality of biomedical science
  • “Young Scientists” session
  • Publication policies – ARRIVE guidelines & Co

More articles

Learn more about what the EUSAAT Congress has to offer.

Subscribe to EUSAAT

Receive regular updates about EUSAAT’s activities, upcoming congresses and seminars. You can find out how we handle your data in our privacy policy. You can unsubscribe at any time free of charge.

Subscription confirmed

Thank you for subscribing to the EUSAAT newsletter. We have added your email to our mailing list.